Dr. Mak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Asb1l2 Radiation Oncology Brigham Womens Hospital
Boston, MA 02115Phone+1 617-732-5500
Summary
- I am an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.
My clinical focus includes the treatment of thoracic malignancies, stereotactic body radiation therapy, and novel image-guided radiation therapy techniques. I led the implementation of the MR-guided radiation therapy program at BWH/DFCI in 2019.
My research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients and applying artificial intelligence techniques to automate radiation therapy planning and improve cancer care.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
- Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
- Harvard Medical SchoolClass of 2006
Certifications & Licensure
- FL State Medical License 2022 - 2026
- RI State Medical License 2021 - 2026
- CT State Medical License 2022 - 2025
- MA State Medical License 2008 - 2025
- ME State Medical License 2020 - 2025
- NH State Medical License 2023 - 2025
- NY State Medical License 2021 - 2023
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) Start of enrollment: 2012 Nov 01
- Jump: MR Simulation For Radiation Therapy Master Protocol Start of enrollment: 2020 Oct 14
Roles: Contact, Principal Investigator
- CONFIRM: Magnetic Resonance Guided Radiation Therapy Start of enrollment: 2021 May 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Treatment Selection for the High-risk Patient with Stage I Non-Small Cell Lung Cancer: Sublobar Resection, Stereotactic Ablative Radiotherapy or Image-guided Thermal A...Arjun Pennathur, Michael Lanuti, Robert E Merritt, Andrea Wolf, Homa Keshavarz
Seminars in Thoracic and Cardiovascular Surgery. 2024-12-09 - Systematic Review of Image-guided Thermal Ablation for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.Michael Lanuti, Robert D Suh, Gerard J Criner, Peter J Mazzone, M Blair Marshall
Seminars in Thoracic and Cardiovascular Surgery. 2024-12-09 - The Importance of Pulmonary Nodule Features in the Selection of Treatment for the High-risk Patient with Stage I Non-Small Cell Lung Cancer.Arjun Pennathur, Michael Lanuti, Robert E Merritt, Andrea Wolf, Homa Keshavarz
Seminars in Thoracic and Cardiovascular Surgery. 2024-12-09
Journal Articles
- Association of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Mortality in Patients with Non–Small Cell Lung CancerKatelyn M Atkins, David E Kozono, Elizabeth H Baldini, Raymond H Mak, JAMA Oncology
Press Mentions
- Making Radiation Therapy Safer for the HeartSeptember 13th, 2024
- Lung Cancer Radiotherapy Linked to Cardiac Complications Due to RadiationAugust 24th, 2024
- AI Helps Predict Cardiac Arrhythmias in Lung Cancer Patients, Research RevealsAugust 23rd, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: